TORL BioTherapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- April 13, 2023
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $158,000,000
Company Info
- Founders
- David Licata
- Company Description
- TORL BioTherapeutics LLC is a clinical-stage biopharmaceutical company with the objective of developing novel, antibody-based therapeutics to transform the lives of cancer patients. Its lead candidate, TORL-1-23, is a CLDN6-directed ADC developed for patients across multiple cancer types.
- Market
- Cancer therapeutics
- Location
- Los Angeles, CA, USA
- Coinvestors
- Alexandria Venture Investments, Bristol Myers Squibb, Cowen Healthcare Investments, Deep Track Capital, Goldman Sachs Asset Management, Moore Strategic Ventures, OCV Partners, Perceptive, Xontogeny Venture Fund, Vertex Ventures